BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Eleftheriadis T, Pissas G, Antoniadi G, Liakopoulos V, Stefanidis I. Factors affecting effectiveness of vaccination against hepatitis B virus in hemodialysis patients. World J Gastroenterol 2014; 20(34): 12018-12025 [PMID: 25232238 DOI: 10.3748/wjg.v20.i34.12018]
URL: https://www.wjgnet.com/1948-5182/full/v20/i34/12018.htm
Number Citing Articles
1
Khalid Eltom, Abrar Albeely, Abdel Rahim M El Hussein, Isam M Elkhidir, Khalid Enan. Occult hepatitis B virus infection in Sudan: A systematic review and meta‐analysisJGH Open 2020; 4(5): 800 doi: 10.1002/jgh3.12411
2
E. Elhanan, M. Boaz, I. Schwartz, D. Schwartz, G. Chernin, H. Soetendorp, A Gal Oz, A. Agbaria, T. Weinstein. A randomized, controlled clinical trial to evaluate the immunogenicity of a PreS/S hepatitis B vaccine Sci-B-Vac™, as compared to Engerix B®, among vaccine naïve and vaccine non-responder dialysis patientsClinical and Experimental Nephrology 2018; 22(1): 151 doi: 10.1007/s10157-017-1416-7
3
Theodoros Eleftheriadis, Georgios Pissas, Vassilios Liakopoulos, Ioannis Stefanidis. Anti-PD1 Immunotherapy for Metastatic Renal Cancer Boosted Humoral Immunity In a Hemodialysis PatientJournal of Immunotherapy 2021; 44(4): 164 doi: 10.1097/CJI.0000000000000365
4
Narges Eslami, Vahdat Poortahmasebi, Javid Sadeghi, Reza Ghotaslou, Bahram Niknafs, Hossein Bannazadeh Baghi, Mahin Ahangar Oskouee, Mejdi Snoussi. Occult Hepatitis B Infection among Hemodialysis Patients in Tabriz, Northwest of Iran: Prevalence and Mutations within the S RegionCanadian Journal of Infectious Diseases and Medical Microbiology 2022; 2022: 1 doi: 10.1155/2022/3838857
5
Ali Asan, Huriye Demirhan, Hülya Çetin Sorkun, Sevgi Özkan, Mehtap Aydın, Davut Akın, Bengü Tatar, Binali Çatak, Alper Şener, Şükran Köse. Factors affecting responsiveness to hepatitis B immunization in dialysis patientsInternational Urology and Nephrology 2017; 49(10): 1845 doi: 10.1007/s11255-017-1616-9
6
Diana Rodríguez-Espinosa, José Jesús Broseta, José Luis Bedini, Néstor Rodríguez, Francisco Maduell. Antibody maintenance and breakthrough infections 6 months after complete COVID-19 vaccination with the mRNA-1273 and BNT162b2 vaccines in hemodialysis patientsClinical Kidney Journal 2022; 15(4): 818 doi: 10.1093/ckj/sfab282
7
Becky Mingyao Ma, Desmond Yat Hin Yap, Terence Pok Siu Yip, Ivan Fan Ngai Hung, Sydney Chi Wai Tang, Tak Mao Chan. Vaccination in patients with chronic kidney disease—Review of current recommendations and recent advancesNephrology 2021; 26(1): 5 doi: 10.1111/nep.13741
8
Ridha H Alkhalifah, Mousa J Alhaddad, Ali T Alhashem, Hussain Alwesaibi, Abdullah A AlKhalaf, Abdullah Albin Saad, Mohammed Almattar, Makarem A Alkhalaf, Habib Alramadhan, Mohammad Albaggal. Prevalence of Hepatitis B Virus, Hepatitis C Virus, and HIV Infections in Hemodialysis Patients at Kano Kidney CenterCureus 2023;  doi: 10.7759/cureus.41769
9
Leslie P. Wong. The Guerilla Tactics of Hepatitis B Virus in Hemodialysis: Fighting a Stubborn FoeKidney Medicine 2019; 1(6): 324 doi: 10.1016/j.xkme.2019.10.003
10
Said A. Al-Busafi, Ahmed Alwassief. Global Perspectives on the Hepatitis B Vaccination: Challenges, Achievements, and the Road to Elimination by 2030Vaccines 2024; 12(3): 288 doi: 10.3390/vaccines12030288
11
Tara Vinyette Saco, Alexandra T. Strauss, Dennis K. Ledford. Hepatitis B vaccine nonrespondersAnnals of Allergy, Asthma & Immunology 2018; 121(3): 320 doi: 10.1016/j.anai.2018.03.017
12
Yongliang Feng, Xiaohong Shi, Jing Shi, Linying Gao, Guangming Liu, Yanpeng Cheng, Minghu Pan, Chunxia Li, Jun Wang, Xuxia Guo, Yawei Zhang, Xiaofeng Liang, Suping Wang. Immunogenicity, antibody persistence, and safety of the 60 μg hepatitis B vaccine in hemodialysis patients: a multicenter, randomized, double-blind, parallel-controlled trialExpert Review of Vaccines 2017; 16(10): 1045 doi: 10.1080/14760584.2017.1367667
13
Joshua Y Kwon, Nader D Daoud, Jana G Hashash, Michael F Picco, Francis A Farraye. Efficacy of Hepatitis B Vaccination with a Novel Immunostimulatory Sequence Adjuvant (Heplisav-B) in Patients With Inflammatory Bowel DiseaseInflammatory Bowel Diseases 2023; 29(2): 254 doi: 10.1093/ibd/izac079
14
Ramy H Agwa, Taher H Elwan, Hashim Abdulrahman S Alghamdi, Abdullah Ali S Alghamdi, Fatema Ibrahim A Altaweel, Abdullah A Alghamdi, Hawraa A Alhussain, Khader Mohammed A Alsawlihah, Faisal A Alzahrani. Awareness of Hepatitis B Virus (HBV) Screening Before Marriage and Pregnancy Among Adults in the Al-Baha Region, Saudi ArabiaCureus 2024;  doi: 10.7759/cureus.52057
15
Xiao-Xia Geng, Zhong Tian, Zhou Liu, Xue-Mei Chen, Kai-Ju Xu. Associations between hepatitis B infection and chronic kidney disease: 10-Year results from the U.S. National Inpatient SampleEnfermedades infecciosas y microbiologia clinica (English ed.) 2021; 39(1): 14 doi: 10.1016/j.eimce.2020.02.012
16
José Jesús Broseta, Diana Rodríguez-Espinosa, José Luis Bedini, Néstor Rodríguez, Francisco Maduell. Antibody maintenance 3 months after complete messenger RNA COVID-19 vaccination in haemodialysis patientsNephrology Dialysis Transplantation 2021; 36(12): 2340 doi: 10.1093/ndt/gfab272
17
Hossein Hatami, Parvaneh Movafagh, Ali Ramezankhani. An Investigation of the Immune Response to Hepatitis B Vaccination in Hemodialysis Patients at Dialysis Centers of Tehran (2016) Journal of Occupational Health and Epidemiology 2019; 8(4): 171 doi: 10.29252/johe.8.4.171
18
Ira M. Jacobson, Robert S. Brown, Brian J. McMahon, Robert P. Perrillo, Robert Gish. An Evidence-based Practical Guide to Vaccination for Hepatitis B VirusJournal of Clinical Gastroenterology 2022; 56(6): 478 doi: 10.1097/MCG.0000000000001695
19
Diana Rodríguez-Espinosa, Elena Cuadrado-Payán, José Jesús Broseta. Management, Body Systems, and Case Studies in COVID-192024; : 423 doi: 10.1016/B978-0-443-18703-2.00051-7
20
Ivan Fan-Ngai Hung, Desmond Yat-Hin Yap, Terence Pok-Siu Yip, Ricky Ruiqi Zhang, Kelvin Kai-Wang To, Kwok-Hung Chan, Sydney Chi-Wai Tang, Sing-Leung Lui, Yotam Levin, Efrat Kochba, Johnson Yiu-Nam Lau, Man-Fung Yuen, Tak-Mao Chan, Kwok-Yung Yuen. A Double-blind, Randomized Phase 2 Controlled Trial of Intradermal Hepatitis B Vaccination With a Topical Toll-like Receptor 7 Agonist Imiquimod, in Patients on DialysisClinical Infectious Diseases 2021; 73(2): e304 doi: 10.1093/cid/ciaa804
21
Sarah E. Bota, Eric McArthur, Kyla L. Naylor, Peter G. Blake, Kevin Yau, Michelle A. Hladunewich, Adeera Levin, Matthew J. Oliver. Long-Term Morbidity and Mortality of Coronavirus Disease 2019 in Patients Receiving Maintenance Dialysis: A Multicenter Population-Based Cohort StudyKidney360 2024; 5(8): 1116 doi: 10.34067/KID.0000000000000490
22
Thilo Kolb, Svenja Fischer, Lisa Müller, Nadine Lübke, Jonas Hillebrandt, Marcel Andrée, Michael Schmitz, Claudia Schmidt, Seher Küçükköylü, Lynn Koster, Margarethe Kittel, Lea Weiland, Karl W. Dreyling, Gerd Hetzel, Ortwin Adams, Heiner Schaal, Katrin Ivens, Lars C. Rump, Jörg Timm, Johannes Stegbauer. Impaired Immune Response to SARS-CoV-2 Vaccination in Dialysis Patients and in Kidney Transplant RecipientsKidney360 2021; 2(9): 1491 doi: 10.34067/KID.0003512021
23
Roisin Connolly, Mark D. Denton, Hilary Humphreys, Rachel M. McLoughlin. Would hemodialysis patients benefit from a Staphylococcus aureus vaccine?Kidney International 2019; 95(3): 518 doi: 10.1016/j.kint.2018.10.023
24
José Jesús Broseta, Diana Rodríguez-Espinosa, Néstor Rodríguez, María del Mar Mosquera, María Ángeles Marcos, Natalia Egri, Mariona Pascal, Erica Soruco, José Luis Bedini, Beatriu Bayés, Francisco Maduell. Humoral and Cellular Responses to mRNA-1273 and BNT162b2 SARS-CoV-2 Vaccines Administered to Hemodialysis PatientsAmerican Journal of Kidney Diseases 2021; 78(4): 571 doi: 10.1053/j.ajkd.2021.06.002
25
Jennifer A. Whitaker, Kenneth Valles, Pritish K. Tosh, Gregory A. Poland. Vaccinations2019; : 139 doi: 10.1016/B978-0-323-55435-0.00009-4
26
Bartholomew Dzudzor, Kingsley Kwame Nsowah, Seth Agyemang, Sandro Vento, Vincent Amarh, Vincent Boima, Kenneth Tachi, Po-Yao Hsu. Overt and occult hepatitis B virus infection detected among chronic kidney disease patients on haemodialysis at a Tertiary Hospital in GhanaPLOS ONE 2024; 19(3): e0290917 doi: 10.1371/journal.pone.0290917
27
Xiao-Xia Geng, Zhong Tian, Zhou Liu, Xue-Mei Chen, Kai-Ju Xu. Associations between hepatitis B infection and chronic kidney disease: 10-Year results from the U.S. National Inpatient SampleEnfermedades Infecciosas y Microbiología Clínica 2021; 39(1): 14 doi: 10.1016/j.eimc.2020.02.029
28
José Jesús Broseta, Diana Rodríguez-Espinosa, Elena Cuadrado, Néstor Rodríguez, José Luis Bedini, Francisco Maduell. Humoral Response after Three Doses of mRNA-1273 or BNT162b2 SARS-CoV-2 Vaccines in Hemodialysis PatientsVaccines 2022; 10(4): 522 doi: 10.3390/vaccines10040522
29
Sawsan M. Abdel-Moniem, Mohammed A. Mohammed, Ziyad M. Essam El-Deen, Hanan M. Mostafa. Effects of interleukin-12 gene polymorphism on response to hepatitis B vaccination among hemodialysis Egyptian patientsThe Egyptian Journal of Internal Medicine 2019; 31(4): 804 doi: 10.4103/ejim.ejim_85_19
30
Casey Light, Karen Heslop, Hemant Kulkarni. Comparison of Factors Affecting the Immune Response to Hepatitis B Vaccination in Patients with Stage 5 Chronic Kidney Disease-haemodialysis and PredialysisThe Open Urology & Nephrology Journal 2024; 17(1) doi: 10.2174/011874303X304324240529133609